GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis

Vieira-Sousa, E; Alves, P; Rodrigues, AM; Teixeira, F; Tavares-Costa, J; Bernardo, A; Pimenta, S; Pimentel-Santos, FM; Gomes, JL; Aguiar, R; Pinto, P; Videira, T; Catita, C; Santos, H; Borges, J; Sequeira, G; Ribeiro, C; Teixeira, L; Avila-Ribeiro, P; Martins, FM; Canhao, H; McInnes, IB; Ribeiro, RM; Fonseca, JE

Vieira-Sousa, E (corresponding author), Univ Lisbon, Inst Med Mol, P-1649028 Lisbon, Portugal.

ANNALS OF THE RHEUMATIC DISEASES, 2020; 79 (4): 490

Abstract

Objectives To assess the efficacy of golimumab in combination with methotrexate (MTX) versus MTX monotherapy in psoriatic arthritis (PsA) dactylitis. ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索